YIT Oyj (0GKA)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 4.245 |
|---|---|
| 52-week range | 2.455 – 4.553 |
| Return, 1 month / 3 months | +12.1% / +62.0% |
| Return, 1 year / 3 years | +52.5% / +142.5% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -26.0% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
YIT Oyj is a construction and development company based in Finland. It builds residential housing for private buyers and constructs business premises, infrastructure and renovation projects for companies and public sector clients. The company also develops entire residential areas and provides maintenance and life-cycle services for buildings and built environments. Its work spans new construction and the repair and modernisation of existing properties, serving customers in Finland and in several other European countries.
The shares are listed on the London Exchange in UK under the code 0GKA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
YIT Oyj (0GKA) trades on the London Exchange in UK. It last closed at EUR 4.245 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 613 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 52.5% and over the last three months it rose 62.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 41.5% | ||
| From 52-week high | -6.8% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 62.0% | ||
| 6-month return | 54.8% | ||
| 12-month return, skipping the last month | 36.1% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.0% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 76.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | +12.1% |
| 3 months | +62.0% |
| 6 months | +54.8% |
| 1 year | +52.5% |
| 3 years | +142.5% |
| 5 years | +4.1% |
Signals
| 50-day / 200-day average | 3.730 / 3.000 |
|---|---|
| Golden / death cross (60 days) | Golden, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.235 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Oct 2023 | EUR 0.0900 |
| 20 Mar 2023 | EUR 0.0900 |
| 3 Oct 2022 | EUR 0.0800 |
| 21 Mar 2022 | EUR 0.0800 |
| 30 Sep 2021 | EUR 0.0700 |
| 19 Mar 2021 | EUR 0.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.